Zuo M - Search Results

1

Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma.

Yuan Q, Yang W, Zhang S, Li T, Zuo M, Zhou X, Li J, Li M, Xia X, Chen M, Liu Y. Yuan Q, et al. Among authors: zuo m. Mol Med. 2021 Jan 28;27(1):7. doi: 10.1186/s10020-020-00261-4. Mol Med. 2021. PMID: 33509092 Free PMC article.

2

IDH1 status is significantly different between high-grade thalamic and superficial gliomas.

Zuo M, Li M, Chen N, Yu T, Kong B, Liang R, Wang X, Mao Q, Liu Y. Zuo M, et al. Cancer Biomark. 2017 Aug 23;20(2):183-189. doi: 10.3233/CBM-170175. Cancer Biomark. 2017. PMID: 28869450

3

[The Research on the Anti-glioma Effect and Mechanism of Cinobufagin].

Kong B, Zuo MR, Liu YH. Kong B, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 May;49(3):388-393. Sichuan Da Xue Xue Bao Yi Xue Ban. 2018. PMID: 30014640 Chinese.

4

A comprehensive study of risk factors for post-operative pneumonia following resection of meningioma.

Zuo MR, Liang RF, Li M, Xiang YF, Zhang SX, Yang Y, Wang X, Mao Q, Liu YH. Zuo MR, et al. BMC Cancer. 2019 Jan 23;19(1):100. doi: 10.1186/s12885-019-5271-7. BMC Cancer. 2019. PMID: 30674295 Free PMC article.

5

The significance of preoperative hematological inflammatory markers in patients with meningiomas.

Liang RF, Li M, Li JH, Zuo MR, Yang Y, Liu YH. Liang RF, et al. Among authors: zuo mr. Clin Neurol Neurosurg. 2019 Jul;182:1-4. doi: 10.1016/j.clineuro.2019.04.020. Epub 2019 Apr 22. Clin Neurol Neurosurg. 2019. PMID: 31048144

6

Risk Factors for Early Mortality Among Patients with Glioma: A Population-Based Study.

Zhou X, Zhang S, Niu X, Li T, Zuo M, Yang W, Li M, Li J, Yang Y, Wang X, Mao Q, Liu Y. Zhou X, et al. Among authors: zuo m. World Neurosurg. 2020 Apr;136:e496-e503. doi: 10.1016/j.wneu.2020.01.041. Epub 2020 Jan 16. World Neurosurg. 2020. PMID: 31954903

7

Engrailed 2 (EN2) acts as a glioma suppressor by inhibiting tumor proliferation/invasion and enhancing sensitivity to temozolomide.

Li T, Yang W, Li M, Zhang S, Zhou X, Zuo M, Yuan Q, Chen M, Liu Y. Li T, et al. Among authors: zuo m. Cancer Cell Int. 2020 Mar 2;20:65. doi: 10.1186/s12935-020-1145-y. eCollection 2020. Cancer Cell Int. 2020. PMID: 32158355 Free PMC article.

8

Clinicopathological characteristics and treatment outcomes of epithelioid glioblastoma.

Sun K, Zhou X, Li T, Zuo M, Li J, Liu Y. Sun K, et al. Among authors: zuo m. Neurosurg Rev. 2021 Dec;44(6):3335-3348. doi: 10.1007/s10143-021-01492-7. Epub 2021 Feb 17. Neurosurg Rev. 2021. PMID: 33598819

9

Elevated GIGYF2 expression suppresses tumor migration and enhances sensitivity to temozolomide in malignant glioma.

Yang W, Yuan Q, Zhang S, Zuo M, Li T, Li J, Zhou X, Li M, Feng W, Xia X, Chen M, Liu Y. Yang W, et al. Among authors: zuo m. Cancer Gene Ther. 2022 Jun;29(6):750-757. doi: 10.1038/s41417-021-00353-1. Epub 2021 May 31. Cancer Gene Ther. 2022. PMID: 34059782

10

Do elderly patients (≥ 75 years old) with glioblastoma benefit from more radical surgeries in the era of temozolomide?

Li T, Liu Y, Li J, Zuo M, Cheng Y. Li T, et al. Among authors: zuo m. Neurosurg Rev. 2022 Feb;45(1):741-750. doi: 10.1007/s10143-021-01600-7. Epub 2021 Jul 9. Neurosurg Rev. 2022. PMID: 34241729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

761 results

Search Page

Filters